Micronase
Micronase

0.54
For patients managing diabetes, this generic medicine triggers insulin release from pancreatic cells. Lowers blood glucose by increasing the body's natural sensitivity to insulin.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Glyburide
Reference Brand
Glyburide
Product Origin
Generic Alternative
Reference Manufacturer
Pfizer
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antidiabetics
Product Category
Sulfonylurea
Pharmacological Class
Antidiabetic
Clinical Indications
Manufacturer Description
Intended to relieve chronic blood sugar elevations to support endocrine balance and target pancreatic beta cells.
Mechanism of Action
Binds to pancreatic ATP-sensitive potassium channels, causing depolarization that stimulates endogenous insulin output.
Route of Administration
Oral
Onset Time
1–3 hours
Duration
12–24 hours
Contraindications
Diabetic ketoacidosis, Type 1 diabetes mellitus, Severe hepatic impairment
Severe Adverse Events
Severe hypoglycemia — requires immediate medical attention, Hemolytic anemia — requires immediate medical attention
Common Side Effects
Nausea, Dizziness, Headache
Uncommon Side Effects
Hypoglycemia, Weight gain, Abdominal fullness
Drug Interactions
NSAIDs, Warfarin, Ciprofloxacin
Pregnancy Safety Warnings
TGA Category C: Use if potential benefits outweigh risks. Monitor newborn. Breastfeeding: Not recommended.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Micronase is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Antibiotics Australia - Keflex Australia